Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07250100 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

Study acronym: MICROPAC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
Trial Details
NCT Number NCT07250100
Lead Sponsor Herlev Hospital
Collaborators: Danish Cancer Society
Conditions
(from sponsor)		 Pancreatic Cancer, Microbiome
Related terms Pancreatic Neoplasms
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov